Products

End-to-end RUO Solution for Mycobacterium Tuberculosis Drug Susceptibility Testing by Sequencing Suited to Small, Medium & High Throughput Laboratories Description The DeepChek® Assay 13-Plex KB Drug Susceptibility Testing V1 allow you to target the most relevant 13 genes and study their associated drug resistance with BacterioChek®-TB software. 1st Line 2nd Line 3rd Line Features Multiplex Amplification

DeepChek® Assay 13-Plex KB Drug Susceptibility Testing Description End-to-end CE-IVD Solution for Mycobacterium Tuberculosis Drug Susceptibility Testing by Sequencing Suited to Small, Medium & High Throughput Laboratories The DeepChek® Assay 13-Plex KB Drug Susceptibility Testing is a single multiplex polymerase chain reaction (PCR) in vitro diagnostic test intended for the amplification of relevant portions of

UltraGene® Assay SARS-CoV-2 VOC Screening & Determination SARS-CoV-2 qPCR Assay to screen the distribution and to determine all currently designated variants of concern (VOCs) Description The UltraGene Assay SARS CoV 2 VOC Screening and Determination V1 (CE IVD) is a rtRT PCR Assay (nucleic acid technique ( intended for the qualitativedetection of SARS CoV 2

UltraGene® Assay SARS-CoV-2 Universalis qPCR Assay to detect specifically the SARS-CoV-2 RNA including current circulating lineages without drop-out or lack of sensitivity Description The UltraGene Assay SARS-CoV-2 Universalis (V2.X) is a real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2 in upper respiratory specimens from individuals suspected of COVID-19 by their

Nadis® Software https://www.nadis.fr/ Présentation de Nadis® Nadis® est un dossier médical informatisé qui est alimenté en temps réel par les professionnels de Santé.Il permet la collecte des données administratives à partir du Système d’Information Hospitalier (SIH) via une interface. Les résultats biologiques sont également incorporés directement dans Nadis® via une interface biologique. Les comptes rendus

Digital Solutions Analysis Software Data Hosting Nadis® Software Computerized medical record Lab. Automation SeqHepB Hepatitis B Viral Genome Analysis

DeepChek® Assay Whole Genome SARS-CoV-2 Genotyping Introduction The DeepChek® Assay Whole Genome SARS-CoV-2 Genotyping  is intended to be used for amplifying whole-genome of severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) in upper respiratory specimens (from individuals already tested positive to SARS-CoV-2). The assay aims to identify SARS-CoV-2 infection by a variant (or lineage) which might

DeepChek® Assay PROTEASE / REVERSE TRANSCRIPTASE Genotyping and Drug Resistance Introduction The DeepChek® Assay -HIV Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance is intended to be used for HIV-1 genotyping and provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). It combines target-specific PCR reagents with in vitro diagnostic software

Technical Support A team at your service Our Field Application Specialist Team can assist you remotely or in your laboratory Anh Thu FACCHIN Customer Care Manager Kevin Ibeas Martínez Field Application Specialist Giuseppina Zuco Field Application Specialist

Careers Open Positions Assistant (e) Commercial(e) en Diagnostic Médical (H/F) France – Marseille More Infos Technicien de Laboratoire R&D (H/F) France – Marseille More Infos